EuroCareFinderExplore healthcare across Europe
← Back to EuroCareFinder

Condition

Retinal Arterial Macroaneurysm

Ophthalmology

Overview

An acquired dilation of the retinal artery often associated with systemic HYPERTENSION.

This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.

Quick facts about Retinal Arterial Macroaneurysm

Topic type
Condition
Category
Ophthalmology
MeSH classification
C11.768.346.500|C14.907.055.908|C14.907.489.815.500

Preparing for an appointment about Retinal Arterial Macroaneurysm

If you are speaking with a healthcare professional about Retinal Arterial Macroaneurysm, it can help to prepare a few details in advance.

  • Write down your symptoms and when they started.
  • Bring details of any medicines, supplements or previous treatments.
  • Ask what tests or assessments may be needed.
  • Ask what treatment or management options may be suitable.
  • Ask when you should seek urgent medical help or follow-up care.

Finding care related to Retinal Arterial Macroaneurysm

EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.

Explore clinics across Europe

Browse the wider EuroCareFinder healthcare network using the interactive map.

Clinics related to Retinal Arterial Macroaneurysm

No clinics are currently linked directly to Retinal Arterial Macroaneurysm on EuroCareFinder.

As more clinics add detailed services, related providers may appear here.

Related topics

Explore healthcare providers

Use EuroCareFinder to browse clinics by country, specialty and available services.

Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.